Ovid Therapeutics Inc. (OVID)
NASDAQ: OVID · IEX Real-Time Price · USD
1.040
+0.101 (10.80%)
At close: Jul 16, 2024, 4:00 PM
1.030
-0.010 (-0.96%)
Pre-market: Jul 17, 2024, 6:37 AM EDT

Ovid Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year Ending
TTM Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019 2018 - 2015
Revenue
0.470.391.5208.3812.620
Upgrade
Revenue Growth (YoY)
283.80%-73.93%-99.28%1551.57%--
Upgrade
Gross Profit
0.470.391.5208.3812.620
Upgrade
Selling, General & Admin
29.9131.0932.4337.2330.6319.25
Upgrade
Research & Development
32.3728.5924.6246.9463.4242.16
Upgrade
Operating Expenses
62.2859.6757.0584.1794.0561.41
Upgrade
Operating Income
-61.81-59.28-55.55124.21-81.43-61.41
Upgrade
Other Expense / Income
-11.13-6.94-1.380.05-0.4-0.95
Upgrade
Pretax Income
-50.68-52.34-54.17124.16-81.04-60.46
Upgrade
Income Tax
0001.3300
Upgrade
Net Income
-50.68-52.34-54.17122.83-81.04-60.46
Upgrade
Shares Outstanding (Basic)
717170675839
Upgrade
Shares Outstanding (Diluted)
717170685839
Upgrade
Shares Change
0.32%0.22%3.46%16.45%49.04%59.22%
Upgrade
EPS (Basic)
-0.73-0.74-0.771.78-1.39-1.54
Upgrade
EPS (Diluted)
-0.73-0.74-0.771.76-1.39-1.54
Upgrade
Free Cash Flow
-50.4-45.82-56.45118.43-51.71-51.15
Upgrade
Free Cash Flow Per Share
-0.71-0.65-0.801.75-0.89-1.30
Upgrade
Gross Margin
100.00%100.00%100.00%100.00%100.00%-
Upgrade
Operating Margin
-13052.08%-15134.60%-3696.44%59.61%-645.40%-
Upgrade
Profit Margin
-10701.80%-13362.17%-3604.66%58.95%-642.26%-
Upgrade
Free Cash Flow Margin
-10643.44%-11698.19%-3756.55%56.83%-409.85%-
Upgrade
Effective Tax Rate
---1.07%--
Upgrade
EBITDA
-49.08-50.74-52.79124.4-80.73-60.21
Upgrade
EBITDA Margin
-10363.78%-12954.57%-3512.73%59.70%-639.83%-
Upgrade
Depreciation & Amortization
1.61.61.380.240.310.26
Upgrade
EBIT
-50.68-52.34-54.17124.16-81.04-60.46
Upgrade
EBIT Margin
-10701.80%-13362.17%-3604.66%59.58%-642.26%-
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).